ADL BIONATUR SOLUT.EO-,05 Logo
ES0184980003
A1XB95
BST.MC

ADL BIONATUR SOLUT.EO-,05

Forecast

There is no analyst data available for this company.

Discussions in the community

There is no discussion about this asset yet.

Start discussion

There is currently no news available for this company. We are working on adding more providers to change this.

Historical dividends Dividends

All dividend metrics All metrics

In 2022, ADL BIONATUR SOLUT.EO-,05 has already paid €0.13 in dividends. The last payout was in June 2022.

Financials

In the last quarter, ADL BIONATUR SOLUT.EO-,05 had revenue of €874.64K and net profit of -€1.18M

(EUR) June 2026
YoY
Revenue 874.64K -
Gross profit -900.71K -
Net profit -1.18M -
EBITDA -346.3K -

Fundamentals

Metric Value
Market capitalization
€16.26M
Number of shares
75.98M
52-week high/low
€0.32 - €0.18
Dividends No
Beta
1.82
P/E ratio
-6.97
PEG ratio
7.16
P/B ratio
2.92
P/S ratio
5.45

Company profile

Biotechnologies Assets SA develops and markets biotechnological assets for application in the biopharmaceutical, agrochemical, cosmetic, veterinary, and chemical industry sectors in Spain and internationally. The company was founded in 1954 and is based in Cádiz, Spain.

Name
ADL BIONATUR SOLUT.EO-,05
CEO
Manuel Lopez Nieto
Headquarters Cádiz, an
Spain
Website
IPO
01/26/2012
Employees 26

Ticker symbols

Exchange Symbol
Bme
BST.MC
Madrid
BST.MC
🍪

Parqet  uses cookies. Learn more